Browse > Article
http://dx.doi.org/10.5483/BMBRep.2017.50.10.043

The anti-microbial peptide SR-0379 stimulates human endothelial progenitor cell-mediated repair of peripheral artery diseases  

Lee, Tae Wook (Department of Physiology, School of Medicine, Pusan National University)
Heo, Soon Chul (Department of Physiology, School of Medicine, Pusan National University)
Kwon, Yang Woo (Department of Physiology, School of Medicine, Pusan National University)
Park, Gyu Tae (Department of Physiology, School of Medicine, Pusan National University)
Yoon, Jung Won (Department of Physiology, School of Medicine, Pusan National University)
Kim, Seung-Chul (Department of Obstetrics and Gynecology, School of Medicine, Pusan National University)
Jang, Il Ho (Department of Oral Biochemistry and Molecular Biology, Pusan National University School of Dentistry)
Kim, Jae Ho (Department of Physiology, School of Medicine, Pusan National University)
Publication Information
BMB Reports / v.50, no.10, 2017 , pp. 504-509 More about this Journal
Abstract
Ischemia is a serious disease, characterized by an inadequate blood supply to an organ or part of the body. In the present study, we evaluated the effects of the anti-microbial peptide SR-0379 on the stem cell-mediated therapy of ischemic diseases. The migratory and tube-forming abilities of human endothelial progenitor cells (EPCs) were enhanced by treatment with SR-0379 in vitro. Intramuscular administration of SR-0379 into a murine ischemic hindlimb significantly enhanced blood perfusion, decreased tissue necrosis, and increased the number of blood vessels in the ischemic muscle. Moreover, co-administration of SR-0379 with EPCs stimulated blood perfusion in an ischemic hindlimb more than intramuscular injection with either SR-0379 or EPCs alone. This enhanced blood perfusion was accompanied by a significant increase in the number of CD31- and ${\alpha}$-SMA-positive blood vessels in ischemic hindlimb. These results suggest that SR-0379 is a potential drug candidate for potentiating EPC-mediated therapy of ischemic diseases.
Keywords
Angiogenesis; Endothelial progenitor cells; Hindlimb ischemia; Peripheral artery diseases; SR-0379;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Brevetti G, Giugliano G, Brevetti L and Hiatt WR (2010) Inflammation in peripheral artery disease. Circulation 122, 1862-1875   DOI
2 Hirsch AT, Treat-Jacobson D, Lando HA and Hatsukami DK (1997) The role of tobacco cessation, antiplatelet and lipid-lowering therapies in the treatment of peripheral arterial disease. Vasc Med 2, 243-251   DOI
3 Jude EB, Oyibo SO, Chalmers N and Boulton AJ (2001) Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome. Diabetes Care 24, 1433-1437   DOI
4 Belch JJ, Topol EJ, Agnelli G et al (2003) Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med 163, 884-892   DOI
5 Youssef F, Gupta P, Mikhailidis DP and Hamilton G (2005) Risk modification in patients with peripheral arterial disease: a retrospective survey. Angiology 56, 279-287   DOI
6 Annex BH (2013) Therapeutic angiogenesis for critical limb ischaemia. Nat Rev Cardiol 10, 387-396   DOI
7 Duan J, Murohara T, Ikeda H et al (2000) Hypercholesterolemia inhibits angiogenesis in response to hindlimb ischemia: nitric oxide-dependent mechanism. Circulation 102, Iii370-376
8 Duan J, Murohara T, Ikeda H et al (2000) Hyperhomocysteinemia impairs angiogenesis in response to hindlimb ischemia. Arterioscler Thromb Vasc Biol 20, 2579-2585   DOI
9 Cheng XW, Kuzuya M, Kim W et al (2010) Exercise training stimulates ischemia-induced neovascularization via phosphatidylinositol 3-kinase/Akt-dependent hypoxiainduced factor-1 alpha reactivation in mice of advanced age. Circulation 122, 707-716   DOI
10 Djonov V, Baum O and Burri PH (2003) Vascular remodeling by intussusceptive angiogenesis. Cell Tissue Res 314, 107-117   DOI
11 Patan S (2004) Vasculogenesis and angiogenesis. Cancer Treat Res 117, 3-32
12 Reyes M, Dudek A, Jahagirdar B, Koodie L, Marker PH and Verfaillie CM (2002) Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest 109, 337-346   DOI
13 Zampetaki A, Kirton JP and Xu Q (2008) Vascular repair by endothelial progenitor cells. Cardiovasc Res 78, 413-421   DOI
14 Hristov M and Weber C (2004) Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance. J Cell Mol Med 8, 498-508   DOI
15 Urbich C and Dimmeler S (2004) Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 95, 343-353   DOI
16 Rouhl RP, van Oostenbrugge RJ, Damoiseaux J, Tervaert JW and Lodder J (2008) Endothelial progenitor cell research in stroke: a potential shift in pathophysiological and therapeutical concepts. Stroke 39, 2158-2165   DOI
17 Krenning G, van Luyn MJ and Harmsen MC (2009) Endothelial progenitor cell-based neovascularization: implications for therapy. Trends Mol Med 15, 180-189   DOI
18 Asahara T, Takahashi T, Masuda H et al (1999) VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. Embo j 18, 3964-3972   DOI
19 Tomioka H, Nakagami H, Tenma A et al (2014) Novel anti-microbial peptide SR-0379 accelerates wound healing via the PI3 kinase/Akt/mTOR pathway. PLoS One 9, e92597   DOI
20 Xu S, Zhu J, Yu L and Fu G (2012) Endothelial progenitor cells: current development of their paracrine factors in cardiovascular therapy. J Cardiovasc Pharmacol 59, 387-396   DOI
21 Nishikawa T, Nakagami H, Maeda A et al (2009) Development of a novel antimicrobial peptide, AG-30, with angiogenic properties. J Cell Mol Med 13, 535-546   DOI
22 Nakagami H, Nishikawa T, Tamura N et al (2012) Modification of a novel angiogenic peptide, AG30, for the development of novel therapeutic agents. J Cell Mol Med 16, 1629-1639   DOI
23 Woo KY, Coutts PM and Sibbald RG (2012) A randomized controlled trial to evaluate an antimicrobial dressing with silver alginate powder for the management of chronic wounds exhibiting signs of critical colonization. Adv Skin Wound Care 25, 503-508   DOI
24 Smith LE, Shen W, Perruzzi C et al (1999) Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor. Nat Med 5, 1390-1395   DOI
25 Rabinovsky ED and Draghia-Akli R (2004) Insulin-like growth factor I plasmid therapy promotes in vivo angiogenesis. Mol Ther 9, 46-55
26 Fan W, Sun D, Liu J et al (2012) Adipose stromal cells amplify angiogenic signaling via the VEGF/mTOR/Akt pathway in a murine hindlimb ischemia model: a 3D multimodality imaging study. PLoS One 7, e45621   DOI